Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Kevin Fielman, PhD

Advertisement

Articles by Kevin Fielman, PhD

De-Risking Trials with Science-Driven Oversight

ByMavys Palacios,Livia Tran,Kevin Fielman, PhD,Charles T. Lancaster,Penelope K. Manasco, MD
March 22nd 2021

Identifying the ‘significant six’ areas of clinical study conduct to mitigate risk.

RBM 1.png

Risk-Based Monitoring Versus Source Data Verification

ByGarrett Manasco,Michelle Pallas,Charlene Kimmel,Everett Lambeth,Deborah Thompson,Sean Bennett, MD, PhD,Kevin Fielman, PhD,Lisa Danzig, MD,Lisa Bedell,Penelope Manasco, MD,Eric Herbel
November 1st 2018

Applied Clinical Trials

Pilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.

Advertisement

Latest Updated Articles

  • De-Risking Trials with Science-Driven Oversight
    De-Risking Trials with Science-Driven Oversight

    March 22nd 2021

  • RBM 1.png
    Risk-Based Monitoring Versus Source Data Verification

    November 1st 2018



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

2

$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret

3

ACT Brief: Real-Time Monitoring Through Quick Wins, Consumer Wearable Validation Requirements, and Replimune RP1 Efficacy Data Advancement

4

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

5

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us